BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8380190)

  • 1. MHC class II limits the functional expression of endogenous superantigens in B cells.
    Lund FE; Randall TD; Woodland DL; Corley RB
    J Immunol; 1993 Jan; 150(1):78-86. PubMed ID: 8380190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
    Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
    Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
    Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
    Asherson GL; Dieli F; Tomonari K
    Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9.
    King LB; Lund FE; White DA; Sharma S; Corley RB
    J Immunol; 1990 Apr; 144(8):3218-27. PubMed ID: 2157765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
    Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
    Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular events during B lymphocyte differentiation. Induction of endogenous mouse mammary tumor proviral envelope transcripts after B cell stimulation.
    Sharma S; King LB; Corley RB
    J Immunol; 1988 Oct; 141(7):2510-8. PubMed ID: 2844901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.
    Choi Y; Kappler JW; Marrack P
    Nature; 1991 Mar; 350(6315):203-7. PubMed ID: 1706480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.
    McMahon CW; Traxler B; Grigg ME; Pullen AM
    Virology; 1998 Apr; 243(2):354-65. PubMed ID: 9568034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.